Gi-Ming Wang, MS

Articles by Gi-Ming Wang, MS

The Negative Impact of the COVID-19 Pandemic on Oncology Care at an Academic Cancer Referral Center

ByJohn Nakayama, MD,Gi-Ming Wang, MS,Gino Cioffi, MPH,Kristin A. Waite, PhD,Nirav Patil, MBBS, MPH,Ravi Kumar Kyasaram, MS,John Shanahan, BA,Paolo Caimi, MD,Jill S. Barnholtz-Sloan, PhD

August 11th 2021

COVID-19 created unexpected delays in oncologic treatment. This study sought to assess the volume of missed cancer-related services due to the pandemic.

Latest Updated Articles

The Negative Impact of the COVID-19 Pandemic on Oncology Care at an Academic Cancer Referral Center
August 11th 2021

Trending on CancerNetwork

FDA Approves Zenocutuzumab in NRG1+ Cholangiocarcinoma Post Systemic Therapy

Daraxonrasib Shows Anti-Tumor Activity in Pretreated RAS+ Pancreatic Cancer

FDA Clears AI Stratification Tool in HR+/HER2– Invasive Breast Cancer

Achieving a “Functional Cure” With Multiple Myeloma Therapy

TIP125 ReDiscover-2, a Phase 3 Study of Zovegalisib (RLY-2608) + Fulvestrant Versus Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-Mutant HR+/ HER2- Breast Cancer Following Recurrence or Progression on or After Treatment With a CDK4/6 Inhibitor (Trial in Progress)